Scientists Develop Vaccine Against Deadly Viruses

Oct 04, 2006

Scientists from the Uniformed Services University of the Health Sciences (USU), in collaboration with counterparts from the Australian Animal Health Laboratory (AAHL), have developed a vaccine to fight two deadly animal viruses that can infect and kill humans and are considered to be potential biological terror agents.

Dr. Christopher C. Broder, professor in the USU Department of Microbiology and Immunology, and Dr. Katharine Bossart, a former graduate student in that department and now postdoctoral fellow at the AAHL, along with their Australian colleagues, explained their vaccine discovery in the Sept. 27th online edition of the Journal of Virology, ahead of print.

Nipah virus and Hendra virus are recently emerged and closely related viral pathogens and both agents are considered to be potential biological terror agents. Nipah virus killed more than 100 people and a million pigs in Malaysia in 1999, while the Hendra virus killed two Australians and 16 horses in Australia's northern state of Queensland in 1994-95. Both viruses are carried by fruit bats in nature and have alarmed scientists with the ease in which they jump from animals to humans.

The new vaccine is composed of a component of the virus particle known as the
G glycoprotein and its use has demonstrated complete protection from infection by Nipah virus in a feline model. Because these viruses are so similar, immunization with the component from either Hendra or Nipah protected against challenge from both, indicating that a single vaccine may be effective against both.

Although members of this group of viruses have only caused a handful of focal outbreaks, the biologic property of these viruses to infect a wide range of hosts and to produce a disease causing significant mortality in humans and the recognition of their reservoirs in nature has made this emerging viral infection a public health concern.

Hendra virus reemerged in Australia in 2004 and 2006, and there have been five recognized outbreaks of human Nipah virus infection in Bangladesh between 2001 and 2005. To date, 102 human cases of Nipah infection have been documented in Bangladesh, and 75 percent of these were fatal. There is evidence that these recent Bangladesh outbreaks have not only direct bat-to-human transmission, but likely human-to-human transmission as well.

There are currently no approved vaccines available for Hendra virus or Nipah virus and no anti-viral drugs available to treat these types of viruses in general. The development and testing of this subunit vaccine was supported by the Middle Atlantic Regional Centers of Excellence and the National Institutes of Health.

Source: Uniformed Services University of the Health Sciences

Explore further: Missing protein restored in patients with muscular dystrophy

add to favorites email to friend print save as pdf

Related Stories

West African bats—no safe haven for malaria parasites

Oct 21, 2013

In Europe, bats are normally discussed in the context of endangered species threatened by loss of their habitats. However, in recent years, bats have caught the eye of infection biologists. The animals are ...

Bats spreading deadly virus, scientist warns

Sep 09, 2013

(Phys.org) —It usually starts with a fever and headache, maybe some coughing and a disoriented feeling. Before long, inflammation of the veins, arteries and brain sets in, a seizure takes hold and you lose consciousness. ...

Will genomics help prevent the next pandemic?

Oct 26, 2009

This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics—with all its associated ...

Recommended for you

Student seeks to improve pneumonia vaccines

23 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

Aug 20, 2014

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

User comments : 0